Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine
- 1 October 1990
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 16 (4), 923-931
- https://doi.org/10.1016/s0735-1097(10)80342-0
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Neurohumoral and hemodynamic changes in congestive heart failure: Lack of correlation and evidence of compensatory mechanismsAmerican Heart Journal, 1988
- In Vivo Induction and Reversal of Nitroglycerin Tolerance in Human Coronary ArteriesNew England Journal of Medicine, 1987
- Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart FailureNew England Journal of Medicine, 1987
- Nitrate Therapy in Stable Angina PectorisNew England Journal of Medicine, 1987
- Heterologous Radioimmunoassay of Atrial Natriuretic Polypeptide in Dog and Rabbit PlasmaJournal of Immunoassay, 1986
- Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.Circulation, 1985
- Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.Cell Metabolism, 1983
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective, randomized trial.Cell Metabolism, 1983
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977